Ameriprise
TEVA icon

Ameriprise’s Teva Pharmaceuticals TEVA Stock Holding History

Ameriprise’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.36M Sell
111,491
-162
-0.1% -$5.21K ﹤0.01% 2692
2025
Q4 		$3.48M Sell
111,653
-19,971
-15% -$492K ﹤0.01% 2692
2025
Q3 		$2.66M Sell
131,624
-116,344
-47% -$2.04M ﹤0.01% 2854
2025
Q2 		$4.16M Buy
247,968
+154,193
+164% +$2.49M ﹤0.01% 2502
2025
Q1 		$1.44M Sell
93,775
-53,874
-36% -$962K ﹤0.01% 3059
2024
Q4 		$3.25M Buy
147,649
+5,494
+4% +$100K ﹤0.01% 2652
2024
Q3 		$2.56M Sell
142,155
-5,562
-4% -$97.3K ﹤0.01% 2777
2024
Q2 		$2.4M Buy
147,717
+51,184
+53% +$788K ﹤0.01% 2785
2024
Q1 		$1.36M Sell
96,533
-1,020
-1% -$12.9K ﹤0.01% 3044
2023
Q4 		$1.02M Buy
97,553
+334
+0.3% +$3.12K ﹤0.01% 3183
2023
Q3 		$993K Buy
97,219
+5,145
+6% +$47.9K ﹤0.01% 3149
2023
Q2 		$693K Sell
92,074
-25,681
-22% -$208K ﹤0.01% 3314
2023
Q1 		$1.04M Sell
117,755
-2,157
-2% -$21.3K ﹤0.01% 3132
2022
Q4 		$1.09M Buy
119,912
+46,525
+63% +$406K ﹤0.01% 3088
2022
Q3 		$592K Sell
73,387
-63,902
-47% -$565K ﹤0.01% 3320
2022
Q2 		$1.03M Sell
137,289
-40,130
-23% -$350K ﹤0.01% 3110
2022
Q1 		$1.66M Buy
177,419
+88,758
+100% +$741K ﹤0.01% 2996
2021
Q4 		$700K Sell
88,661
-7,125
-7% -$64.3K ﹤0.01% 3405
2021
Q3 		$933K Sell
95,786
-33,817
-26% -$317K ﹤0.01% 3191
2021
Q2 		$1.28M Sell
129,603
-101,621
-44% -$1.08M ﹤0.01% 3119
2021
Q1 		$2.67M Sell
231,224
-20,107
-8% -$231K ﹤0.01% 2742
2020
Q4 		$2.42M Sell
251,331
-285,116
-53% -$2.73M ﹤0.01% 2694
2020
Q3 		$4.83M Buy
536,447
+198,491
+59% +$2.1M ﹤0.01% 2111
2020
Q2 		$4.17M Sell
337,956
-254,557
-43% -$2.88M ﹤0.01% 2198
2020
Q1 		$5.32M Sell
592,513
-13,003
-2% -$133K ﹤0.01% 1868
2019
Q4 		$5.93M Buy
605,516
+302,970
+100% +$2.7M ﹤0.01% 2128
2019
Q3 		$2.08M Buy
302,546
+81,765
+37% +$626K ﹤0.01% 2674
2019
Q2 		$2.04M Buy
220,781
+61,539
+39% +$742K ﹤0.01% 2748
2019
Q1 		$2.5M Sell
159,242
-40,492
-20% -$714K ﹤0.01% 2636
2018
Q4 		$3.08M Sell
199,734
-33,340
-14% -$683K ﹤0.01% 2431
2018
Q3 		$5.01M Buy
233,074
+47,293
+25% +$1.1M ﹤0.01% 2337
2018
Q2 		$4.51M Sell
185,781
-8,252
-4% -$168K ﹤0.01% 2313
2018
Q1 		$3.32M Buy
194,033
+97,322
+101% +$1.9M ﹤0.01% 2453
2017
Q4 		$1.86M Sell
96,711
-1,356,425
-93% -$20.4M ﹤0.01% 2685
2017
Q3 		$25.6M Sell
1,453,136
-1,131,229
-44% -$25.5M 0.01% 890
2017
Q2 		$85.9M Buy
2,584,365
+1,295,794
+101% +$40.1M 0.04% 396
2017
Q1 		$41.3M Buy
1,288,571
+756,441
+142% +$25.8M 0.02% 617
2016
Q4 		$19.3M Buy
532,130
+32,692
+7% +$1.31M 0.01% 1022
2016
Q3 		$23M Buy
499,438
+12,741
+3% +$665K 0.01% 853
2016
Q2 		$24.4M Sell
486,697
-2,275,886
-82% -$121M 0.01% 800
2016
Q1 		$148M Buy
2,762,583
+274,158
+11% +$16.1M 0.09% 228
2015
Q4 		$163M Buy
2,488,425
+234,209
+10% +$14.5M 0.1% 208
2015
Q3 		$127M Sell
2,254,216
-142,460
-6% -$9.24M 0.08% 246
2015
Q2 		$142M Buy
2,396,676
+307,552
+15% +$19M 0.08% 244
2015
Q1 		$130M Buy
2,089,124
+98,873
+5% +$5.75M 0.07% 265
2014
Q4 		$114M Buy
1,990,251
+196,689
+11% +$11M 0.07% 296
2014
Q3 		$96.4M Sell
1,793,562
-11,371
-0.6% -$602K 0.06% 325
2014
Q2 		$94.6M Buy
1,804,933
+161,211
+10% +$8.24M 0.06% 320
2014
Q1 		$86.9M Sell
1,643,722
-151,339
-8% -$6.99M 0.05% 345
2013
Q4 		$71.9M Sell
1,795,061
-80,437
-4% -$3.17M 0.04% 399
2013
Q3 		$70.9M Buy
1,875,498
+217,198
+13% +$8.47M 0.05% 421
2013
Q2 		$65M Buy
+1,658,300
New +$64.6M 0.05% 440

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise's TEVA Position: Q1 2026 in Review

Ameriprise reduced its Teva Pharmaceuticals (TEVA) stake by 0.15% in Q1 2026, selling an estimated $5.21K and leaving 111,491 shares worth $3.36M. The position accounts for ﹤0.01% of the portfolio, ranked #2692.

Ameriprise first reported a position in TEVA in Q2 2013 and has held it in 52 quarters since. The position peaked at $163M in Q4 2015. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Ameriprise held 111,491 shares of Teva Pharmaceuticals worth $3.36M as of Q1 2026.
  • Ameriprise sold 162 Teva Pharmaceuticals shares in Q1 2026, an estimated $5.21K.
  • Teva Pharmaceuticals made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #2692 holding.
  • Ameriprise first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • Ameriprise's Teva Pharmaceuticals position peaked at $163M in Q4 2015.
  • 650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.